Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Jan 6;15(1):961.
doi: 10.1038/s41598-024-83757-x.

Stability of refractive outcomes after hyperopic LASIK with and without Mitomycin C application: a randomized controlled trial

Amr Saad  1   2   3 , Johannes Steinberg  4   5 , Andreas Frings  6   7
Affiliations
Randomized Controlled Trial

Stability of refractive outcomes after hyperopic LASIK with and without Mitomycin C application: a randomized controlled trial

Amr Saad et al. Sci Rep. .

Abstract

To assess the efficacy, safety, and stability of refractive outcomes in hyperopic Laser-Assisted in Situ Keratomileusis (LASIK) with and without the application of Mitomycin C (MMC). This randomized, parallel group, controlled multicenter trial included 140 hyperopic eyes. The participants were randomly assigned to two groups: one receiving LASIK with mitomycin C (MMC) (n = 70) and the other receiving LASIK without MMC (n = 70). The primary outcome measures were uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and safety parameters at six months postoperatively. The statistical analysis employed t-tests, Mann-Whitney tests, and Fisher's Exact Test, with a significance level of p < 0.05. All 140 eyes (70 per group) were analyzed. No statistically significant differences were identified between the two groups in postoperative UDVA, CDVA, or safety parameters (p > 0.05). Both groups demonstrated highly effective and safe refractive outcomes. No intraoperative complications or postoperative adverse events were observed. Age and preoperative spherical equivalent did not significantly affect outcomes. Hyperopic LASIK with and without MMC showed comparable efficacy, safety, and stability of refractive outcomes at the six-month postoperative interval. Although MMC use in hyperopic LASIK appears to be a safe procedure, it was not found to be significantly superior to conventional LASIK. Further investigation with longer follow-up periods and larger cohorts is necessary to confirm these results.

Keywords: Laser-in-Situ-Keratomileusis; MMC; Mitomycin C; Refractive outcome; Refractive surgery.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Standard graphs reporting visual outcomes for treatment groups (Group A: LASIK with MMC; Group B: LASIK without MMC): (A) Efficacy graph, (B) Safety graph, (C) Accuracy graph, (D) Residual cylinder graph; (E) Predictability graph; LASIK: Laser-Assisted in Situ Keratomileusis, MMC: Mitomycin C, UDVA: uncorrected distance visual acuity, CDVA: corrected distance visual acuity, SEQ: spherical equivalent (F) Stability graph; 3 m: 3 months postoperatively, 6 m: 6 months postoperatively.
Fig. 2
Fig. 2
Standard graphs reporting visual outcomes for age-related groups (Group A: 20–45 years old, Group B: 45–54 years old): (A) Efficacy graph, (B) Safety graph, (C) Accuracy graph, (D) Residual cylinder graph; (E) Predictability graph; LASIK: Laser-Assisted in Situ Keratomileusis, MMC: Mitomycin C, UDVA: uncorrected distance visual acuity, CDVA: corrected distance visual acuity, SEQ: spherical equivalent (F) Stability graph; 3 m: 3 months postoperatively, 6 m: 6 months postoperatively.
Fig. 3
Fig. 3
Correlation graph of pre- and postoperative spherical equivalent (SEQ).
Fig. 4
Fig. 4
Correlation graph of preoperative and absolute postoperative SEQ.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Wen, D. et al. Postoperative efficacy, predictability, Safety, and visual quality of laser corneal refractive surgery: a Network Meta-analysis. Am. J. Ophthalmol.178, 65–78. 10.1016/j.ajo.2017.03.013 (2017). - PubMed
    1. Alió, D. et al. Femtosecond Laser-assisted in situ Keratomileusis for the treatment of moderate to high hyperopia. J. Cataract Refract. Surg.10.1097/j.jcrs.0000000000001153 (2023). - PubMed
    1. Moshirfar, M. et al. Mechanisms of Optical Regression following corneal laser refractive surgery: epithelial and stromal responses. Med. Hypothesis Discov Innov. Ophthalmol.7, 1–9 (2018). - PMC - PubMed
    1. Kaluzny, B. J. et al. Three-year outcomes after high hyperopia correction using photorefractive keratectomy with a large ablation zone. Br. J. Ophthalmol.103, 849–854. 10.1136/bjophthalmol-2017-311694 (2019). - PubMed
    1. Gauthier-Fournet, L., Penin, F. & Arba Mosquera, S. Six-Month outcomes after high hyperopia correction using laser-assisted in situ keratomileusis with a large ablation zone. Cornea38, 1147–1153. 10.1097/ico.0000000000002011 (2019). - PubMed

Publication types

LinkOut - more resources